BACKGROUND AND OBJECTIVES: Novel therapeutic agents and strategies have been introduced into the management of myelodysplastic syndromes (MDS) in the last years. This has led to more treatment options and a better chance of long-term survival for MDS patients, but also to uncertainty regarding the optimal use and possible side effects of these treatments. The Italian Society of Hematology commissioned a project to develop guidelines for the therapy of MDS using evidence-based knowledge and consensus-formation techniques. DESIGN AND METHODS: An Advisory Council (AC) shaped the project around a series of key clinical questions, performed a systematic search for evidence and graded the available evidence according to the Scottish Intercollegia...
PURPOSE AND BASIC PROCEDURE OF THE STUDY: The availability of new targeted therapies has revolutioni...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characte...
Myelodysplastic syndromes (MDS) are a poorly understood group of disorders caused by one or more gen...
Background and Objectives. Novel therapeutic agents and strategies have been introduced into the man...
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet, an Expert Panel ...
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet, an Expert Panel ...
Item does not contain fulltextWithin the MDS work-package of the European LeukemiaNet, an Expert Pan...
BACKGROUND AND OBJECTIVE: There are several therapeutic options for patients with myeiodysplastic sy...
The heterogeneous group of myelodysplastic syndromes (MDS) needs an individualized and patient-tailo...
Myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant hematopoietic stem cell ...
Purpose and basic procedure of the study: The availability of new targeted therapies has revolutioni...
Introduction. Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal haematopoiet...
Since 2002, date of publication of the previous Italian Society of Haematology (SIE) practice guidel...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characte...
Myelodysplastic syndromes (MDSs) constitute a heterogeneous group of clonal hematopoietic disorders....
PURPOSE AND BASIC PROCEDURE OF THE STUDY: The availability of new targeted therapies has revolutioni...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characte...
Myelodysplastic syndromes (MDS) are a poorly understood group of disorders caused by one or more gen...
Background and Objectives. Novel therapeutic agents and strategies have been introduced into the man...
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet, an Expert Panel ...
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet, an Expert Panel ...
Item does not contain fulltextWithin the MDS work-package of the European LeukemiaNet, an Expert Pan...
BACKGROUND AND OBJECTIVE: There are several therapeutic options for patients with myeiodysplastic sy...
The heterogeneous group of myelodysplastic syndromes (MDS) needs an individualized and patient-tailo...
Myelodysplastic syndromes (MDS) comprise a heterogeneous group of malignant hematopoietic stem cell ...
Purpose and basic procedure of the study: The availability of new targeted therapies has revolutioni...
Introduction. Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal haematopoiet...
Since 2002, date of publication of the previous Italian Society of Haematology (SIE) practice guidel...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characte...
Myelodysplastic syndromes (MDSs) constitute a heterogeneous group of clonal hematopoietic disorders....
PURPOSE AND BASIC PROCEDURE OF THE STUDY: The availability of new targeted therapies has revolutioni...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological disorders characte...
Myelodysplastic syndromes (MDS) are a poorly understood group of disorders caused by one or more gen...